Fewer seed rounds and alternative financing strategies: They chose to collaborate with patient associations

The current context of early-stage capital shortage has an impact on all stakeholders in life sciences. Alternative financing strategies are not only a nice way to move forward for innovation but for some it has become necessary to survive and bring their asset to patients in need. Among these strategies, some chose to collaborate with patient associations. Through their case studies, speakers will discuss the role these alternative financing players took in the deal and how it compares to other types of partnerships, and the outcomes of the collaborations.